Important note: Information in this article was accurate in 2007. The state of the art may have changed since the publication date.
![]()

Reuters NewMedia - January 16, 2007
Evelyn Leopold
In a 44-page report, "Children and Aids: A Stocktaking," the U.N. children's agency said one out of 10 pregnant women living in capital cities in sub-Saharan Africa is infected with HIV, the virus that causes AIDS. In Pretoria, South Africa, for example, one in four children is infected.
"Increasing numbers of children living with HIV are now receiving treatment, although the numbers are far too few," the report said. "The increases are a result of improved testing, better skills among health workers, lower drug prices and simpler formulations."
While only nine per cent of HIV-positive pregnant women in low- and middle-income countries worldwide received drugs in 2005 that could prevent passing on the disease to children, the figure represented an increase from three percent in 2003.
In Namibia, access rates to drugs for pregnant women jumped from six to 29 per cent from 2004 to 2005. In Swaziland, it rose to 34 percent from four percent and in South Africa, the increase was to 30 percent from 22 percent.
According to available data, only seven countries in 2005 provided treatment, known as antiviral prophylaxis, to more than 40 per cent of HIV-infected pregnant women: Argentina, Brazil, Botswana, Jamaica, Russia, Thailand and Ukraine.
The study found the most successful results in nations that instituted a decentralized approach to service and training, a demonstrated a political commitment and incorporated care for the entire family, from prevention to treatment.
But there are still 2.3 million children under 15 living with HIV around the world and only 10 percent in need of antroviral drugs had access to them, UNICEF said.
An estimated one-third of infected infants die in their first year, and half die by their second birthday.
070116
RE070115
Copyright © 2007 - Reuters, Ltd. All rights reserved. Republication or redistribution of Reuters content is expressly prohibited without the prior written consent of Reuters. Reuters shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon. Contact Reuters.
AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Boehringer Ingelheim, Bridgestone/Firestone Charitable Trust, Elton John AIDS Foundation UK, the National Library of Medicine, AIDS Walk of Orange County, and donations from users like you.
Always watch for outdated information. This article first appeared in 2007. This material is designed to support, not replace, the relationship that exists between you and your doctor.
AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.
Copyright ©1980, 2007. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .